Balt
Montmorency
About Balt
BALT has worked with neurovascular surgeons to treat complex life-threatening conditions such as strokes, aneurysms and arteriovenous malformations. A pioneer in its field, BALT designs, manufactures and distributes the ‘Interventional Neuro Radiology’ (‘INR’) devices such as catheters, stents and coils that are essential in treating such conditions. BALT is one of the leading pure play MedTech companies in Europe, and is a supplier to all major international hospitals practicing neuroradiology surgery.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $370.3M
- Funding stage: M&A
- Last round: Debt Financing (Dec 2024)
- Website: balt.fr
- Phone: +33139894641
Industries & Categories
Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/balt-71193 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.